A Phase II study of Epitinib in glioblastoma with EGFR gene amplification.
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Epitinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 29 Aug 2016 New trial record
- 02 Aug 2016 According to Chi-Med media release, company is planning to start this trial in early 2017.